Today: 21 March 2026
Subscribe
Browse Category

NASDAQ:MTVA 6 December 2025

MetaVia Inc. (MTVA) Stock Jumps After Reverse Split: What the New Price, Trial Data and 2026 Forecast Mean for Investors

MetaVia Inc. (MTVA) Stock Jumps After Reverse Split: What the New Price, Trial Data and 2026 Forecast Mean for Investors

MetaVia Inc. (NASDAQ: MTVA) completed a 1-for-11 reverse stock split on December 4, 2025, sending its share price to $8.18, up nearly 12% in 24 hours. The company, now valued at about $17 million, remains early-stage with no product revenue and a staff of nine. Trading volume and volatility remain high. MetaVia’s lead drug candidates target obesity and metabolic liver disease.
6 December 2025
·

Stock Market Today

  • Fundrise Lists Venture-Focused Innovation Fund VCX on NYSE
    March 20, 2026, 7:55 PM EDT. Fundrise, an online investment platform, has launched its Fundrise Innovation Fund (VCX) on the New York Stock Exchange (NYSE). This marks the first publicly traded venture fund from Fundrise, opening access to individual investors regardless of wealth. Top holdings include private companies like Anthropic, OpenAI, SpaceX, and Epic Games. VCX has a 1.85% management fee and began trading recently, though it was launched in July 2022. Since inception, VCX has achieved an 84.44% return, with a 13.43% gain year-to-date. Initial trading prices are around $120 per share. Fundrise's move into venture funds complements its roots in real estate crowdfunding and presents a new liquidity avenue for private securities owners.
Go toTop